Skip to content

Evaluation of Aesthetic Impact in Patients With Systemic Sclerosis

Evaluation of Aesthetic Impact in Patients With Systemic Sclerosis

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03271320
Acronym
SCLERO-ESTHET
Enrollment
170
Registered
2017-09-05
Start date
2016-12-19
Completion date
2018-03-01
Last updated
2026-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Systemic Sclerosis

Brief summary

The primary objective is to assess the burden of aesthetic complication in systemic sclerosis. Systemic sclerosis is associated with changes in skin aspect which can impact the appearance. Aesthetic burden will be assessed through several scales and compared to a control group of health subjects.

Interventions

OTHERappearance scales

appearance scales : AVS; ASWAP; DAS 59

Sponsors

University Hospital, Lille
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* systemic sclerosis according to ACR-EULAR 2013

Exclusion criteria

* non French native * aesthetic sequel from other conditions

Design outcomes

Primary

MeasureTime frameDescription
Visual scale for aesthetic burdenBaselineVisual scale for aesthetic burden from 0 to 10

Secondary

MeasureTime frameDescription
Satisfaction with Appearance Scale (SWAP)BaselineThe SWAP measures body image dissatisfaction in persons with visible disfigurement
Derriford Appearance Scale-59 (DAS)BaselineThe Derriford Appearance Scales measure the spectrum of psychological distress and dysfunction that is characteristic of disfigurements, deformities and aesthetic problems of appearance.
Multidimensional Body self Relations Questionnaire (MBSRQ)BaselineThe Multidimensional Body-Self Relations Questionnaire (MBSRQ) is a 69-item self-report inventory for the assessment of self-attitudinal aspects of the body-image construct.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 6, 2026